Prevalence of esophagogastric varices in patients with non-alcoholic steatohepatitis

Hepatology Research

Volumn 38, Issue 6, 2008, Pages 572-579

  Nakamura, Shinichi ^a   Konishi, Hiroyuki ^a   Kishino, Maiko ^a   Yatsuji, Satoru ^a   Tokushige, Katsutoshi ^a   Hashimoto, Etsuko ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Esophageal varices; Gastric varices; Liver cirrhosis; NASH; Portal hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IOPAMIDOL; LIPID; MONOETHANOLAMINE OLEATE; OLDAMIN; POLIDOCANOL;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARGON PLASMA COAGULATION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PORTAL HYPERTENSION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; STOMACH VARICES; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; VEIN LIGATION;

EID: 43049125490     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00318.x     Document Type: Article

References (30)

1. Harrison SA, Torgerson S, Hayashi PH. The natural history of non-alcoholic fatty liver disease: A clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-7.
2. Ono M, Saibara T. Clinical features of non-alcoholic steatohepatitis in Japan: Evidence from literature. J Gastroenterol 2006; 41: 725-32.
3. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GKK, Sollano JD, The Asia-Pacific Working Party on NAFLD. Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-87.
4. Shimada M, Hashimoto E, Taniai M et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002; 37: 154-60.
5. Ratziu V, Bonyhay L, Di Martino V et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35: 1485-93.
6. Hashimoto E, Yatsuji S, Kaneda H et al. The characteristics and natural history of Japanese patients with non-alcoholic fatty liver disease. Hepatol Res 2005; 33: 72-6.
7. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Non-alcoholic steatohepatitis: Mayo Cinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
8. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
9. Hui JM, Kench JG, Chitturi S et al. Long-term outcomes of cirrhosis in non-alcoholic steatohepatitis compared with hepatitis C. Hepatology 2003; 38: 420-7.
10. Sanyal AJ, Banas C, Sargeant C et al. Similarities and differences in outcomes of cirrhosis due to non-alcoholic steatohepatitis and hepatitis C. Hepatology 2006; 43: 682-9.
11. Cales P, Desmorat H, Vinel JP et al. Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding. Gut 1990; 31: 1298-302.
12. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999; 94: 3292-6.
13. Jensen DM. Endoscopic screening for varices in cirrhosis: Findings, implications, and outcomes. Gastroenterology 2002; 122: 1620-30.
14. Madhotra R, Mulcahy HE, Willner I et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002; 34: 81-5.
15. Sanyal AJ. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
16. Brunt EM. Non-alcoholic steatohepatitis. Semin Liver Dis 2004; 24: 3-19.
17. Neuschwander-Tetri BA, Caldwell SH. Non-alcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19.
18. Adams LA, Sanderson S, Lindor KD et al. The histological course of non-alcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-8.
19. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
20. The Japan Society for Portal Hypertension. The General Rules for Study of Portal Hypertension, 2nd edn. Tokyo: Kanehara Co., 2004; 37-50.
21. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527-32.
22. Saeed ZA, Stiegmann GV, Ramirez FC et al. Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial. Hepatology 1997; 25: 71-4.
23. Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 1987; 7: 810-15.
24. Nakamura S, Mitsunaga A, Murata Y, Suzuki S, Hayashi N. Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: A prospective randomized trial of ligation plus APC vs. ligation alone. Endoscopy 2001; 33: 210-15.
25. Cipolletta L, Bianco MA, Rotondano G, Marmo R, Meucci C, Piscopo R. Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: Preliminary results of a prospective randomized trial. Gastrointest Endosc 2002; 56: 467-71.
26. Kanagawa H, Mima H, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11: 51-8.
27. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-4.
28. Sanyal AJ, Fontana RJ, Di Bisceglie AM et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006; 64: 855-64.
29. Levy C, Zein CO, Gomez J et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 803-8.
30. Kaneda H, Hashimoto E, Yatsuji S, Tokushige K, Shiratori K. Hyaluronic acid levels can predict severe fibrosis and platelet counts predict cirrhosis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2006; 21: 1459-65.